pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
VS-041
Diastolic Heart Failure (HFpEF)
Vasa Therapeutics SP Zoo
0
catalysts
Phase 1
VS-105
Secondary Hyperparathyroidism
Vidasym Inc
0
catalysts
Phase 2
VT-3989
Malignant Pleural Mesothelioma
Vivace Therapeutics Inc
0
catalysts
Phase 1
VT-A
← prev
page 147 of 231
next →
131
Pain
89
Neurology
1
Pulmonary Arterial Hypertension
VasThera Co Ltd
0
catalysts
Preclinical
VTA-100
Limb-Girdle Muscular Dystrophy
Vita Therapeutics Inc
0
catalysts
Preclinical
VTI-1002
Bullous Pemphigoid
viDA Therapeutics Inc
0
catalysts
Phase 1
VTP-1000
Celiac Disease
$BRNS
Barinthus Biotherapeutics plc.
0
catalysts
Phase 2
VTR-297
Onychomycosis (Tinea Unguium)
$VNDA
Vanda Pharmaceuticals Inc.
0
catalysts
Preclinical
VTRU-200
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Vitruviae LLC
0
catalysts
Preclinical
VTX-803
Progressive Familial Intrahepatic Cholestasis
Vivet Therapeutics SAS
0
catalysts
Preclinical
VTX-806
Cerebrotendinous Xanthomatosis
Vivet Therapeutics SAS
0
catalysts
Phase 2
VTx-002
Amyotrophic Lateral Sclerosis
VectorY Therapeutics Inc
0
catalysts
VUSION
VUSION (MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM)
MYLAN
0
catalysts
Preclinical
VV-169
Refractory Multiple Myeloma
$NVS
NOVARTIS AG
0
catalysts
Preclinical
VV-2003
Enterocolitis
Vivreon Biosciences LLC
0
catalysts
Preclinical
VV-8325
Alzheimer's Disease
Vivreon Biosciences LLC
0
catalysts
Phase 1
VVD-037
Solid Tumor
Vividion Therapeutics Inc
0
catalysts
Phase 1
VVD-850
Non-Small Cell Lung Cancer
Vividion Therapeutics Inc
0
catalysts
Phase 2
VVN-001
Keratoconjunctivitis Sicca (Dry Eye)
VivaVision Biotech Ltd
0
catalysts
Phase 2
VVN-461
Ocular Inflammation
VivaVision Biotech Ltd
0
catalysts
Phase 2
VX-407
Polycystic Kidney Disease
$VERX
Vertex, Inc.
0
catalysts
Phase 2
VXAG-1.1NN
Norovirus Infections
$VXRT
Vaxart, Inc.
0
catalysts
Preclinical
VXAHPV-16.1
Human Papillomavirus (HPV) Associated Cancer
$VXRT
Vaxart, Inc.
0
catalysts
Phase 1
VXCO-100
Coronavirus Disease 2019 (COVID-19)
Vaccine Company Inc
0
catalysts
Phase 2
VXM-01
Recurrent Glioblastoma Multiforme (GBM)
Vaximm AG
0
catalysts
Phase 1
VXS-1219
Influenza A Virus, H7N9 Subtype Infections
Vaxxas Pty Ltd
0
catalysts
Preclinical
VY-1706
Alzheimer's Disease
$VYGR
Voyager Therapeutics, Inc.
0
catalysts
Phase 2
VY-7523
Alzheimer's Disease
$VYGR
Voyager Therapeutics, Inc.
0
catalysts
Phase 1
VYN-202
Fibrosis
$VYNE
VYNE Therapeutics Inc.
0
catalysts
Preclinical
VZHE-039
Sickle Cell Disease
IllExcor Therapeutics LLC
0
catalysts
